Publications

Local ligand concentration gradients induced by the plasma membrane
Szabó Á, Tóth G, Szatmári T, Mocsár G, Rebenku I, Szöllősi J, Nagy P
iScience, 28: 112954 (2025)
Pubmed
DOI

In both experimental and applied medicine, it seems trivial that if we want to stimulate a receptor located in the cell membrane from the extracellular space, then we increase the concentration of the ligand in the extracellular space to a given, typically nanomolar-micromolar value, and we believe that this concentration is more or less homogeneous in the space around the cells. We have demonstrated by fluorescence correlation spectroscopy measurements that this assumption is not fulfilled for the epidermal growth factor (EGF), since the concentration of EGF showed one or two peaks around the cells. The peak located a few micrometers from the membrane (A), which appeared around all EGF receptor-expressing cells, is the consequence of the active membrane turnover. EGF bound to the receptor is almost immediately endocytosed, and some of these vesicles immediately release their contents back into the extracellular space. When this active membrane turnover was inhibited, the ligand concentration peak close to the cell membrane disappeared. When the cells also expressed the ErbB2 receptor, another concentration peak was also created or strengthened, which was 10-20 micrometers away from the membrane (B). The extracellular matrix produced by the cells is responsible for this phenomenon, which on the one hand slows down the diffusion and on the other hand, as a result, locally increases the concentration of EGF. These results have far-reaching consequences, since the above-described active functions of the cell or the cell membrane significantly influence concentrations measured around the cell membrane, so when a ligand is administered, be it an experimentally applied agent or a drug used in clinical practice, the expected and actual concentrations may differ significantly.

Effect of the Lipid Landscape on the Efficacy of Cell-Penetrating Peptides
Zákány F, Mándity IM, Varga Z, Panyi G, Nagy P, Kovács T
Cells, 12: 1700 (2023) 
Pubmed
DOI

Cell-penetrating peptides (CPPs)  are able to traverse the obstacle presented by the cell membrane to deliver membrane impermeable drugs to intracellular targets. Given that cellular entry mechanisms including both energy-independent direct translocation and energy-dependent endocytic processes involve permeation through cellular membranes, the general biophysical properties of membranes can substantially influence the efficiency of cellular entry and thus the biological effects and therapeutic potential of CPP-cargo complexes. In this review, we summarized the entry mechanisms of CPPs and the general principles how the biophysical properties of membranes can alter these processes. Furthermore, we provide a brief overview of disorders such as diabetes mellitus, Alzheimer’s disease and various tumors, in which CPP-mediated drug delivery shows great therapeutic promise. However, we argue that alterations in the membrane lipid composition intrinsically associated with these disorders and consequent changes in bilayer properties could extensively reduce therapeutic efficacy of CPP-cargo complexes, and therefore, a beneficial combination with membrane lipid therapies can be expected to enhance the drug delivery mediated by CPPs.

Improved estimation of the ratio of detection efficiencies of excited acceptors and donors for FRET measurements
Batta Á, Hajdu T, Nagy P
Cytometry A, 103: 563-574 (2023)
Pubmed
DOI

The most common method of measuring FRET involves measuring the donor and acceptor intensities separately. To calculate the FRET efficiency, the two intensity values obtained are calibrated using a complex system of equations. Our aim was to determine the exact ratio of the intensities of the excited donor and excited acceptor, denoted by alpha, required for the calibration.
Traditionally, in FRET measurements, alpha is determined by determining the intensity of samples labelled with the same number of donors and acceptors. However, if it is determined on a small number of cells, e.g., in a microscope, this shortcoming introduces a large statistical error (A). The statistical error can be reduced by measuring the cells by flow cytometry, as much more cells can be examined in a short period of time.
One of the innovations introduced in our experiments was to use microbeads with a calibrated number of antibody binding sites, labelled with fluorescently stained antibodies, instead of cells. Much more accurate measurement results are obtained using the microbeads (B).
Further improvement in reproducibility was achieved by labeling cell or bead samples with a mixture of antibodies containing both donor and acceptor. This modification gave even better results as it eliminated the need for comparing the intensities of two different samples (C). Since the proposed method does not require specialized instrumentation, it can enjoy widespread application in the calibration of intensity-based FRET measurements.